(April 5, 2019, 9:18 AM EDT) -- BOSTON — Drug makers Jazz Pharmaceuticals PLC, Lundbeck LLP and Alexion Pharmaceuticals Inc. will pay a combined $122.6 million to resolve allegations that the drug companies violated the False Claims Act, 31 U.S. Code § 3729, by paying kickbacks to patients through charitable foundations that paid co-pays for patients prescribed the companies expensive drugs, the U.S. Attorney’s Office for the District of Massachusetts announced April 4....